Josefin-Beate (Josi) Holz
Josi is a serial entrepreneur and experienced executive leader with a broad background in drug development in oncology, haematology, inflammation and immunology. She has generated a track record in successful execution of translational medicine and acceleration of drug development from research stage into clinical proof of concept and towards product registration for a significant number of small molecule drug candidates and biologics, including mAbs and novel protein drug formats. In her role as executive management member, Josi has built development functions “from scratch” and successfully combined project and portfolio management with corporate objectives - e.g. financing, partnering and licensing to maximise the value of projects towards commercialisation. As MD with training in oncology, Josi started her career with BMS in 1995 and has since then worked internationally with prestigious large and mid size Pharma companies (Gilead, OSI, LEO Pharma) and SMEs in the Biotechnology sector (U3 Pharma, GPC Biotech, Ablynx NV).